Scientists discovered chloronitramide anion in chloramine-treated drinking water, highlighting potential health risks and a need for further toxicity research.
Scientists have uncovered a new chemical compound lurking in U.S. drinking water, potentially exposing one in five Americans to an unidentified health risk.
Researchers at the University of Arkansas have identified chloronitramide anion, a previously unknown byproduct of water disinfection that could have implications for public health, according to a new study published on Nov. 21 in Science. Continue reading
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb’s cancer cell therapies and vaccines from France’s Sanofi at the start of 2025, according to data analyzed by healthcare research firm 3 Axis Advisors. 
Executive Summary
Medicinal herbs and their phytocompounds are being increasingly considered to be helpful in alternative cancer treatments. Many clinical studies have reported the benefits of herbal medicines on cancer patients’ survival, immune modulation, and quality of life.
A middle school student from Chicago has helped discover a surprising ingredient that could safeguard against cancer.
Fructose — which is added to thousands of US food and drinks — was found to speed up the growth of certain kinds of skin, breast and cervical tumors. The study showed this type of sugar gets converted by the liver into components that tumors need to build new cells and grow.
The shirt on your back, the carpet beneath your feet, and the takeout container from last night’s dinner share a troubling secret: They’re slowly breaking down into invisible particles that are turning up everywhere, from Mount Everest’s peak to your bloodstream.
I would hope, think, that after a few hundred years in business and taking trillions of dollars out of our pockets that the medical profession would have its collective shit together, but every day they disprove that thought. This last transition from the sublime to the ludicrous, lowered my expectations to 
~ Introduction ~
The diagnosis of prostate cancer relies heavily on the results of a prostate biopsy. A pathologist will analyze the biopsy and assignment a Gleason score or grade. Gleason scores reflect how likely it is that it tumor will spread. The score can vary between 2 and 10 where 2 indicates a small likelihood of spread and 10 indicates a high likelihood of spread. The oncologist will also determine the size of the tumor, if there are cancer cells in nearby lymph nodes or if there is any cancer present in distant tissues (metastasis). The choice of conventional treatment is based on PSA level, Gleason scores, and other information about the prostate tumor. Unfortunately, a negative biopsy (no disease seen) does not exclude the diagnosis of prostate cancer (i.e., a false negative result). 